The TESCREAL bundle: Eugenics and the promise of utopia through artificial general intelligence
By Timnit Gebru and Émile P. Torres,
First Monday
| 04. 14. 2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can and should be built, researchers are working to create “safe AGI” that is “beneficial for all of humanity.” We argue that, unlike systems with specific applications which can be evaluated following standard engineering principles, undefined systems like “AGI” cannot be appropriately tested for safety. Why, then, is building AGI often framed as an unquestioned goal in the field of AI? In this paper, we argue that the normative framework that motivates much of this goal is rooted in the Anglo-American eugenics tradition of the twentieth century. As a result, many of the very same discriminatory attitudes that animated eugenicists in the past (e.g., racism, xenophobia, classism, ableism, and sexism) remain widespread within the movement to build AGI, resulting in systems that harm marginalized groups and centralize power, while using the language of “safety” and “benefiting humanity” to evade...
Related Articles
Flag of South Africa; design by Frederick Brownell,
image by WikimediaCommons users.
Public domain, via Wikimedia Commons
What is the legal status of heritable human genome editing (HHGE)? In 2020, a comprehensive policy analysis by Baylis, Darnovsky, Hasson, and Krahn documented that more than 70 countries and an international treaty prohibit it, and that no country explicitly permits it. Policies in some countries were non-existent, ambiguous, or subject to possible amendment, but the general rule remained, even after one...
By Bernice Lottering, Gene Online | 11.08.2024
South Africa’s updated health-research ethics guidelines, which now include heritable human genome editing, have sparked concern among scientists. The revisions, made in May but only recently gaining attention, outline protocols for modifying genetic material in sperm, eggs, or embryos—changes that...
By Jim Thomas, Scan the Horizon | 11.19.2024
It’s the wee hours of 2nd November 2024 in Cali, Colombia. In a large UN negotiating hall Colombian Environment Minister Susana Muhamed has slammed down the gavel on a decision that should send a jolt through the AI policy world. ...
By Ned Pagliarulo, BioPharmaDive | 11.05.2024
A medicine built around a more precise form of CRISPR gene editing appeared to work as designed in its first clinical trial test, developer Beam Therapeutics said Tuesday. But the death of a trial participant could renew concerns about an older...